Rutherrin(R), when combined with a common diabetic drug and radiation, was able to effectively destroy Non-Hodgkin's Lymphoma ...

Regeneron last year won European Commission approval of odronextamab as Ordspono for relapsed/refractory follicular lymphoma or diffuse large B-cell lymphoma after two or more lines of systemic ...

FDA decision expected by July 30, 2025TARRYTOWN, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) ...

Studies reveal that over 50% of food samples in India have pesticide residues beyond safe limits, linking them to increased ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission ...

Another young harder thrower will be on the mound Wednesday for the Red Sox. He was added to the 40-man roster in November after being up to 98-99 mph last year.

A YOUNG Ryedale woman who has battled cancer three times over the last decade is hosting a a charity ball to raise funds for organisations that ...

It’s really important to continue to focus on ensuring that those who devote their lives to protecting the public and communities continue to receive coverage through the special claims unit,” said ...

Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...

Since his wife died, David Morris has devoted his life to driving cancer patients to hospitals around the region. Now, the charity he supports ...

StockNews.com initiated coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Free Report) in a research report released on Tuesday morning. The firm issued a hold rating on the specialty ...

Melissa Coulier, co-founder of Live Well Lead Well, uses holistic wellness to aid Dave's cancer journey and help others ...